DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS Stock

Certificat

DE000ME9Z603

Real-time Bid/Ask 05:20:29 2024-07-03 EDT
6.6 EUR / 7.09 EUR +0.07% Intraday chart for DISCOUNT OPTIONSSCHEIN - CELSIUS HLDGS
Current month+1.63%
1 month+116.46%
Date Price Change
24-07-02 6.84 +4.11%
24-07-01 6.57 -2.38%
24-06-28 6.73 0.00%
24-06-27 6.73 -2.32%
24-06-26 6.89 -1.57%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 01:51 pm

More quotes

Static data

Product typeProduits Exotiques
Buy / SellPUT
Underlying CELSIUS HOLDINGS, INC.
Issuer Morgan Stanley
WKN ME9Z60
ISINDE000ME9Z603
Date issued 2024-03-08
Strike 70 $
Maturity 2024-09-20 (80 Days)
Parity 1 : 1
Emission price 2.59
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 7.02
Lowest since issue 1.47
Spread 0.49
Spread %6.90%

Company Profile

Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a fitness drink or supplement which, with exercise, is designed to accelerate metabolism and burn body fat while providing energy. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. The Company also offers a new CELSIUS Essentials line, available in 16-ounce cans. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce. Additionally, the Company's products are also offered in certain Canadian, European, Middle Eastern and Asia-Pacific markets. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C.
Sector
-
More about the company

Ratings for Celsius Holdings, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

Consensus: Celsius Holdings, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
57.24 USD
Average target price
83.43 USD
Spread / Average Target
+45.76%
Consensus